Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], undetermined digital illustration

Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], undetermined Save


ICD-10 code: T48.1X4

Chapter: Injury, poisoning and certain other consequences of external causes

Poisoning by Skeletal Muscle Relaxants [Neuromuscular Blocking Agents], Undetermined

Skeletal muscle relaxants, also known as neuromuscular blocking agents (NMBAs), are medications that cause temporary paralysis of the skeletal muscles. These drugs are commonly used during surgical procedures to facilitate intubation, as well as in the treatment of certain medical conditions such as muscle spasms and dystonia. While these medications are generally safe when used appropriately, poisoning by NMBAs can occur in certain circumstances.

Poisoning by NMBAs can occur accidentally, as in cases where a patient is given too high of a dose during surgery. It can also occur intentionally, as in cases of suicide or homicide. Symptoms of NMBA poisoning include muscle weakness, respiratory distress, and loss of consciousness. If left untreated, NMBA poisoning can lead to respiratory failure and death.

Diagnosing NMBA poisoning can be difficult, as the symptoms are similar to other conditions such as myasthenia gravis and Guillain-Barre syndrome. However, there are certain tests that can be done to confirm a diagnosis of NMBA poisoning, such as measuring the level of acetylcholine receptor antibodies in the blood.

  1. Prevention is key in avoiding NMBA poisoning. Healthcare providers should be familiar with the appropriate dosages of these medications and should monitor patients closely for signs of toxicity.
  2. If NMBA poisoning is suspected, immediate treatment is necessary. This may include administration of medications such as neostigmine to reverse the effects of the NMBA.
  3. In severe cases of NMBA poisoning, mechanical ventilation may be necessary to support the patient's breathing.
  4. Follow-up care is important in ensuring a full recovery from NMBA poisoning. Patients may need to undergo physical therapy to regain strength and mobility.

In conclusion, poisoning by skeletal muscle relaxants, or NMBAs, can occur accidentally or intentionally and can be life-threatening if left untreated. Healthcare providers should take appropriate precautions to prevent NMBA poisoning and should be familiar with the signs and symptoms of toxicity. If NMBA poisoning is suspected, immediate treatment is necessary to prevent respiratory failure and death.